PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Supplementation significantly decreased total cholesterol, triglycerides, and LDL levels [PMID:30935518, PMID:33040642].
Barberry significantly reduces insulin levels [PMID:32507431] and is used to regulate glucose levels in type 2 diabetic patients [PMID:39413550].
Supplementation did not have a significant effect on systolic or diastolic blood pressure [PMID:33197673].
B. vulgaris showed beneficial effects in reducing LDL, total cholesterol, triglycerides, and glucose [PMID:33040642].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 30637820 (2019) — Berberine and barberry (Berberis vulgaris): A clinical review. · Phytotherapy research : PTR
- 2.PMID: 27671811 (2016) — Berberine and Its Role in Chronic Disease. · Advances in experimental medicine and biology
- 3.PMID: 10767672 (2000) — Berberine. · Alternative medicine review : a journal of clinical therapeutic
- 4.PMID: 28656092 (2017) — Berberis vulgaris: specifications and traditional uses. · Iranian journal of basic medical sciences
- 5.PMID: 28656087 (2017) — Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review. · Iranian journal of basic medical sciences